Departments of aNephrology
bPharmacy, IDIBELL, Bellvitge University Hospital
cDepartment of Pharmacy and Pharmaceutical Technology, Biopharmaceutics and Pharmacokinetics Unit, School of Pharmacy, University of Barcelona, Barcelona, Spain
dDepartment of Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute
eLouvain Centre for Toxicology and Applied Pharmacology, Experimental and Clinical Research Institute, Catholic University of Louvain, Brussels, Belgium
Departments of fInternal Medicine
gHospital Pharmacy
hClinical Biochemistry, Erasmus MC, University Medical Center Rotterdam, The Netherlands
*Ron van Schaik and Josep M. Grinyó contributed equally to the writing of this article.
Correspondence to Nuria Lloberas, PhD, Department of Nephrology, Bellvitge University Hospital, 4122 Nephrology laboratory, Pabellón del gobierno, 4th floor, Feixa Llarga S/N, Hospitalet de Llobregat, 08907 Barcelona, Spain Tel/fax: +34 934 035 806; e-mail: [email protected]
Received September 28, 2016
Accepted June 7, 2017
